IP Library Granted Patent US 11,548,909
Granted Patent B2
US 11,548,909 · App. 15/928,562 · Granted Jan 10, 2023

Methods of using nucleotide analogues

Inventors: Mong Sano Marma (Natick, MA); Jerzy Olejnik (Brookline, MA); Ilia Korboukh (Needham, MA)
Assignee: IsoPlexis Corporation
C07H19/10C07C323/12C07C323/60C07D207/46C07F7/1804C07H19/14C09B1/00C09B5/2436C09B11/24C09B23/083C09B23/166C12Q1/6811C12Q1/6869C12Q1/6876C07C2603/18Y02P20/55
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,548,909
App. No.
15/928,562
Granted
Jan 10, 2023
Kind
B2
Abstract

The present invention provides methods, compositions, mixtures and kits utilizing deoxynucleoside triphosphates comprising a 3′-O position capped by a group comprising methylenedisulfide as a cleavable protecting group and a detectable label reversibly connected to the nucleobase of said deoxynucleoside. Such compounds provide new possibilities for future sequencing technologies, including but not limited to Sequencing by Synthesis.

Claims (8)

1. A method for analyzing a DNA sequence comprising the steps of

a) providing a nucleic acid template with a primer hybridized to said template forming a primer/template hybridization complex,

b) adding DNA polymerase, and a first deoxynucleoside triphosphate comprising a nucleobase and a sugar selected from a mixture of at least 4 differently labeled, 3′-O methylenedisulfide capped deoxynucleoside triphosphate compounds having the structures:

c) subjecting said reaction mixture to conditions which enable a DNA polymerase catalyzed primer extension reaction so as to create a modified primer/template hybridization complex, and

d) detecting said first detectable label of said labeled 3′-O methylenedisulfide capped deoxynucleoside triphosphate in said modified primer/template hybridization complex,

e) removing said cleavable protecting group, and

f) repeating steps b) to e) at least once.

2. The method according to claim 1 , wherein the mixture of at least 4 differently labeled, 3′-O methylenedisulfide capped deoxynucleoside triphosphate compounds further comprises at least one unlabeled methylenedisulfide capped deoxynucleoside triphosphate compound, wherein the unlabeled 3′-O methylenedisulfide capped deoxynucleoside triphosphate compound is selected from:

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2023
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: ISOPLEXIS CORPORATION
Reel/Frame 063235/0942 →
PATENT PURCHASE AGREEMENT Recorded Jul 30, 2021
From: QIAGEN SCIENCES, LLC
To: ISOPLEXIS CORPORATION
Reel/Frame 057043/0629 →
SECURITY AGREEMENT Recorded May 28, 2021
From: ISOPLEXIS CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 056421/0929 →
MERGER Recorded Jun 13, 2018
From: QIAGEN WALTHAM, INC.
To: QIAGEN SCIENCES LLC
Reel/Frame 046351/0474 →
CHANGE OF NAME Recorded May 23, 2018
From: INTELLIGENT BIO-SYSTEMS, INC.
To: QIAGEN WALTHAM, INC.
Reel/Frame 046376/0700 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2018
From: MARMA, MONG SANO; OLEJNIK, JERZY; KORBOUKH, ILIA
To: INTELLIGENT BIO-SYSTEMS, INC.
Reel/Frame 045794/0537 →
Continuity (4)
Continuation 15343279 · Nov 4, 2016
Provisional Application 62327555 · Apr 26, 2016
Provisional Application 62251884 · Nov 6, 2015
Related Publication 20180274025A1 · Sep 27, 2018